Management of Hepatitis C Virus (HCV) Infection in Pregnant Women With Opioid Use Disorder (OUD): the Potential of an Integrated Medical Home Model: Phase IV Trial of Sofosbuvir/Velpatasvir (SOF/VEL) in Postpartum Women With Chronic HCV
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 08 Jan 2019 Planned End Date changed from 1 Dec 2019 to 1 Feb 2021.
- 08 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Feb 2020.
- 07 Mar 2018 Status changed from not yet recruiting to recruiting.